- Home
- FPAY vs APM Comparison
FPAY vs APM Comparison
Compare FPAY & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- APM
- Stock Information
- Founded
- FPAY 2003
- APM 2010
- Country
- FPAY United States
- APM United Kingdom
- Employees
- FPAY N/A
- APM N/A
- Industry
- FPAY Diversified Commercial Services
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- FPAY Consumer Discretionary
- APM Health Care
- Exchange
- FPAY Nasdaq
- APM Nasdaq
- Market Cap
- FPAY 18.3M
- APM 18.9M
- IPO Year
- FPAY N/A
- APM 2018
- Fundamental
- Price
- FPAY $0.42
- APM $2.11
- Analyst Decision
- FPAY Strong Buy
- APM
- Analyst Count
- FPAY 2
- APM 0
- Target Price
- FPAY $2.25
- APM N/A
- AVG Volume (30 Days)
- FPAY 755.4K
- APM 434.9K
- Earning Date
- FPAY 11-12-2025
- APM 04-30-2025
- Dividend Yield
- FPAY N/A
- APM N/A
- EPS Growth
- FPAY N/A
- APM N/A
- EPS
- FPAY N/A
- APM N/A
- Revenue
- FPAY $139,800,732.00
- APM N/A
- Revenue This Year
- FPAY $19.71
- APM N/A
- Revenue Next Year
- FPAY N/A
- APM N/A
- P/E Ratio
- FPAY N/A
- APM N/A
- Revenue Growth
- FPAY 19.51
- APM N/A
- 52 Week Low
- FPAY $0.27
- APM $0.46
- 52 Week High
- FPAY $2.37
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- FPAY 31.44
- APM 54.18
- Support Level
- FPAY $0.27
- APM $1.74
- Resistance Level
- FPAY $0.68
- APM $2.45
- Average True Range (ATR)
- FPAY 0.07
- APM 0.19
- MACD
- FPAY -0.04
- APM 0.04
- Stochastic Oscillator
- FPAY 26.58
- APM 48.10
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.